Adlai Nortye to Present at the Biotech Showcase™ Annual Conference on January 9
2018.01.02
Return

Hangzhou, China/ Dec 30 2017 – Adlai Nortye Biopharma Co., Ltd./ Jason Lu, Chief Business Officer, today announced that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.

1514874061.png

Jason Lu, Chief Business Officer, will present at the Biotech Showcase™ as follows:

Date: Tuesday, January 9, 2018

Time: 15:00-15:30 (PST)

Room: Hilton/Yosemite C, Level Ballroom Level

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)


Adlai Nortye™ is a biopharmaceutical company dedicated to discovering and commercializing of new drugs. Through close collaborations with global partners, Adlai Nortye™ has successfully positioned itself in the fields of immuno-oncology and bolic diseases and have several programs ongoing from early pre-clinical to phase 3 ready. 


Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.


Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Adlai Nortye will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”


About Adlai Nortye™

Adlai Nortye is a science-led biopharmaceutical company dedicated to discovering, developing and commercializing new drugs. We focus on discovering and developing important new treatments for cancer and bolic diseases. Our mission is to improve patient lives by identifying and acquiring differentiated innovative medicines that help people live better, live longer.


Contacts

Johnson Zhang (VP/Secretary of Board Directors)

Tel: 86-571-28918382

Email: johnson.zhang@adlainortye.com

Visit: http://www.adlainortye.com